Analysis of agreement among definitions of metabolic syndrome in nondiabetic Turkish adults: a methodological study

Table 4 Anthropometric and biochemical data of subjects categorized as metabolic syndrome according to each studied definition.

	WHO-MS	EGIR-MS	NCEP-MS	ACE-MS	IDF-MS
Age (years)*	47 ± 12	46 ± 12	48 ± 12	48 ± 12	48 ± 12
BMI (kg/m²)*	33 ± 5	33 ± 5	32 ± 4	31 ± 5	32 ± 5
SBP (mmHg)*	145 ± 22	144 ± 23	145 ± 24	143 ± 24	144 ± 25
DBP (mmHg)*	93 ± 12	92 ± 12	92 ± 12	91 ± 12	91 ± 12
Glucose (mmol/l)*	5.4 ± 0.6	5.3 ± 0.6	5.2 ± 0.6	5.1 ± 0.6	5.2 ± 0.6
Insulin (pmol/l)†	96.1 (81.6, 119.1)	96.1 (82.3, 118.6)	66.0 (47.4, 92.6)	63.9 (44.5, 90.4)	64.6 (45.9, 90.6)
HOMA-IR†	3.14 (2.64, 4.03)	3.12 (2.65, 4.03)	2.13 (1.48, 3.00)	2.00 (1.36, 2.89)	2.08 (1.44, 2.95)
Framingham risk score*	2.99 ± 4.64	2.79 ± 4.45	3.22 ± 4.81	3.08 ± 4.71	3.04 ± 4.67
Women:
Frequency‡	18%	19%	43%	44%	48%
Waist (cm)*	102.8 ± 9.7	101.3 ± 10.1	99.6 ± 9.7	97.6 ± 10.9	98.2 ± 10.2
TC (mmol/l)*	4.99 ± 1.13	4.94 ± 1.13	4.95 ± 1.06	4.92 ± 1.10	4.91 ± 1.05
HDL-C (mmol/l)*	1.07 ± 0.26	1.06 ± 0.27	1.06 ± 0.23	1.05 ± 0.22	1.07 ± 0.23
LDL-C (mmol/l)*	3.06 ± 0.97	3.04 ± 0.96	3.09 ± 0.91	3.06 ± 0.95	3.05 ± 0.89
TG (mmol/l)†	1.72 (1.30, 2.34)	1.70 (1.26, 2.29)	1.59 (1.19, 2.13)	1.67 (1.21, 2.18)	1.57 (1.13, 2.07)
Men:
Frequency‡	23%	25%	41%	48%	46%
Waist (cm)*	107.0 ± 8.3	106.9 ± 8.12	105.3 ± 8.5	102.9 ± 9.1	105.2 ± 7.1
TC (mmol/l)*	4.89 ± 0.91	4.85 ± 0.90	4.87 ± 0.84	4.78 ± 0.88	4.82 ± 0.90
HDL-C (mmol/l)*	0.92 ± 0.22	0.91 ± 0.22	0.89 ± 0.20	0.87 ± 0.19	0.91 ± 0.22
LDL-C (mmol/l)*	2.90 ± 0.81	2.88 ± 0.79	2.90 ± 0.74	2.83 ± 0.78	2.90 ± 0.80
TG (mmol/l)†	2.08 (1.52, 2.69)	2.05 (1.41, 2.62)	2.10 (1.69, 2.71)	2.03 (1.59, 2.68)	1.92 (1.42, 2.53)

Please see list of abbreviations used. *mean ± SD are given for normally distributed variables, †median (25^th and 75^th percentile values) are given for variables with a skewed distribution ‡the frequency of men or women with the metabolic syndrome according to each definition.

ISSN: 1471-2458